Heart failure with preserved ejection fraction: mechanisms and treatment strategies

K Omote, FH Verbrugge… - Annual review of medicine, 2022 - annualreviews.org
Approximately half of all patients with heart failure (HF) have a preserved ejection fraction,
and the prevalence is growing rapidly given the aging population in many countries and the …

The physiology and pathophysiology of T-tubules in the heart

IE Setterberg, C Le, M Frisk, H Perdreau-Dahl… - Frontiers in …, 2021 - frontiersin.org
In cardiomyocytes, invaginations of the sarcolemmal membrane called t-tubules are critically
important for triggering contraction by excitation-contraction (EC) coupling. These structures …

The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy

SK Sanganalmath, S Dubey, S Veeranki… - Cardiovascular …, 2023 - Springer
Diabetes mellitus is one of the prime risk factors for cardiovascular complications and is
linked with high morbidity and mortality. Diabetic cardiomyopathy (DCM) often manifests as …

Flavonoids: Potential therapeutic agents for cardiovascular disease

Y Liu, J Luo, L Peng, Q Zhang, X Rong, Y Luo, J Li - Heliyon, 2024 - cell.com
Flavonoids are found in the roots, stems, leaves, and fruits of many plant taxa. They are
related to plant growth and development, pigment formation, and protection against …

Vasohibin inhibition improves myocardial relaxation in a rat model of heart failure with preserved ejection fraction

DM Eaton, BW Lee, MA Caporizzo, A Iyengar… - Science Translational …, 2024 - science.org
Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome associated
with increased myocardial stiffness and cardiac filling abnormalities. Prior studies implicated …

RyR2 and calcium release in heart failure

JP Benitah, R Perrier, JJ Mercadier, L Pereira… - Frontiers in …, 2021 - frontiersin.org
Heart Failure (HF) is defined as the inability of the heart to efficiently pump out enough blood
to maintain the body's needs, first at exercise and then also at rest. Alterations in Ca2+ …

Cardiac transverse tubules in physiology and heart failure

KM Dibb, WE Louch, AW Trafford - Annual review of physiology, 2022 - annualreviews.org
In mammalian cardiac myocytes, the plasma membrane includes the surface sarcolemma
but also a network of membrane invaginations called transverse (t-) tubules. These …

Three tyrosine kinase inhibitors cause cardiotoxicity by inducing endoplasmic reticulum stress and inflammation in cardiomyocytes

H Wang, Y Wang, J Li, Z He, SA Boswell, M Chung… - BMC medicine, 2023 - Springer
Abstract Background Tyrosine kinase inhibitors (TKIs) are anti-cancer therapeutics often
prescribed for long-term treatment. Many of these treatments cause cardiotoxicity with limited …

Pathophysiological insights into HFpEF from studies of human cardiac tissue

AU Fayyaz, M Eltony, LJ Prokop, KE Koepp… - Nature Reviews …, 2024 - nature.com
Heart failure with preserved ejection fraction (HFpEF) is a major, worldwide health-care
problem. Few therapies for HFpEF exist because the pathophysiology of this condition is …

Myocardial inflammation in heart failure with reduced and preserved ejection fraction

P Alcaide, M Kallikourdis, R Emig… - Circulation Research, 2024 - Am Heart Assoc
Heart failure (HF) is characterized by a progressive decline in cardiac function and
represents one of the largest health burdens worldwide. Clinically, 2 major types of HF are …